SPY330.65-3.85 -1.15%
DIA276.52-2.38 -0.85%
IXIC10,793.28-117.00 -1.07%

ThermoGenesis To Roll Out A 'Comprehensive Diagnostic And Therapeutic Product Line' For COVID-19

RANCHO CORDOVA, Calif., Sept 2, 2020 /PRNewswire/ --ThermoGenesis Holdings, Inc. (NASDAQ:THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, along with its

· 09/02/2020 08:38

RANCHO CORDOVA, Calif., Sept 2, 2020 /PRNewswire/ --ThermoGenesis Holdings, Inc. (NASDAQ:THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, along with its joint venture, ImmuneCyte, Inc. today announced plans to roll out a comprehensive diagnostic and therapeutic product line to fight the global COVID-19 pandemic. The multi-pronged strategy will combine diagnostic, therapeutic and service offerings to better detect, track and fight the novel coronavirus. Details regarding the strategy will be included in the company's presentation at the LD Micro 500 Conference on Wednesday, September 2 at 5 p.m. EST.

A live webcast of the presentation will be available on the ThermoGenesis website at: https://ThermoGenesis.com/investors/news-and-events/events-webcasts.